Occlutech GmbH
JENA, Germany, October 28, 2011 -
Occlutech, a leading European developer of septum occluders such as PFO and ASD devices as well as other innovative, minimally invasive cardiac implants, today announced that it got a favorable ruling in patent litigation with St Jude-AGA Medical from the District Court of Milan in Italy.
JENA, Germany, September 26, 2011 -
Occlutech, a leading European developer of implants for treating structural heart disease today announced that its CEO, Mr Tor Peters, has obtained a favorable ruling from the district court in Dsseldorf in patent litigation initiated personally against him by St Jude AGA Medical.
JENA, Germany, May 12, 2011 - Occlutech GmbH, a leading European developer of minimally invasive
implants for the treatment of structural heart disease, today announced that
it has received a favourable court ruling from the German Supreme Court,
(BGH), in Karlsruhe, Gerrmany in patent litigation initiated by AGA Medical
Inc., now part of St.
JENA, Germany, March 4, 2011 - Occlutech GmbH, a leading European developer of minimally invasive
implants for the treatment of structural heart disease, today announced that
it has received a favourable court ruling from Stockholm, Sweden in the
on-going patent litigation with AGA Medical -St Jude Medical.
JENA, Germany, October 22, 2010 - Occlutech GmbH, the leading European developer of minimally invasive
implants for the treatment of structural heart disease, today announced
receiving a favourable appeal court ruling from The Hague, The Netherlands in
the on-going patent litigation with AGA Medical.
